Deverra is a clinical-stage biotechnology company developing universal donor cell therapy treatments to fight cancer and other life-threatening diseases.
Investors 1
| Date | Name | Website |
| 10.07.2026 | 5AM Ventur... | 5amventure... |
Mentions in press and media 1
| Date | Title | Description |
| 19.09.2023 | Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies | Colleen Delaney, the founder, chief scientific officer, and executive vice president of research and development at Deverra Therapeutics. (Fred Hutch Photo) Seattle biotech company Deverra Therapeutics is raising cash for its cellular immun... |